FindTrial
Sign In

Effectiveness of Mifepristone and Misoprostol V/S Misoprostol alone in the induction of labor- a Randomised Controlled Trial

effectiveness of Mifepristone and Misoprostol vs Misoprostol alone in the induction of labor- a randomised conttolled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053518
Enrollment
226
Registered
2023-06-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Tab Mifepristone and tab misoprostol: GROUP A PATIENTS: It consists of 113 patients .They received T. Mifepristone 200mg orally on day 1 which is followed by T. Misoprostol 25 mcg intra

Sponsors

Dr Sneha Chakraborty
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1) Women with Ultrasonographically confirmed Singleton pregnancy of 37-42weeksduration 2) Cephalic presentation 3) No contraindications to vaginal delivery 4) Post dated pregnancies 5) Reactive FHR 6) Bishop score 7) Rh negative pregnancies 8) Intact membranes

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Previous Lower Segment Cesarean Section (LSCS). 2. Intra Uterine Growth Restriction (IUGR). 3. Oligohydramnios. 4. Malpresentation. 5. Associated medical disorder (hypertension, diabetes mellitus, heart disease, anemia, thyroid, epilepsy, asthma). 6. Premature Rupture of Membrane (PROM). 7. Congenital Anomaly. 8. Hypersensitivity to Prostaglandins & Mifepristone. 9. Preeclampsia, Eclampsia. 10. Placental insufficiency. 11. Cephalo Pelvic Disproportion. 12. Patient not willing to participate

Design outcomes

Primary

MeasureTime frame
Primary Objective â?? To determine the effectiveness of mifepristone and misoprostol V/S misoprostol alone in induction of labor.Timepoint: 1 year—

Secondary

MeasureTime frame
Secondary Objective â?? To determine the feto maternal outcome in both the groups.Timepoint: 1 year—

Countries

India

Contacts

Public ContactSneha Chakraborty

jawaharlal nehru medical college,belagavi,prabhakar kore charitable hospital

kamalpatil1967@yahoo.co.in9845565454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026